NNSA Readies New Funding Deals for Medical Isotope Production

By ExchangeMonitor

ARLINGTON, Va. — The U.S. National Nuclear Security Administration (NNSA) could soon award a new tranche of funding to support U.S. commercial manufacturing of the medical isotope molybdenum-99, a senior official said this week. “We’re working through…

Thank you for visiting
Weapons Complex Morning Briefing!

You must be logged in as a subscriber to view this page.

Not a subscriber? Click here to subscribe.

Please contact [email protected] if you are unable to login.

Forgot Password?

Comments are closed.

Table of Contents

First W76-2 Finished at Pantex in January, NNSA Says

By ExchangeMonitor
NNSA to Hone Procurement Approach for SRS Pit Plant by Next Year

By ExchangeMonitor
DOE Manager to Lead Both Hanford Offices

By ExchangeMonitor
SRNS Chief Foresees Contract Extension

By ExchangeMonitor
SRNS, Feds Wait on Advisory Opinion in $5M Overcharging Lawsuit

By ExchangeMonitor
Hanford Occupational Medicine Provider Earns 90% of Fee in Latest Scorecard

By ExchangeMonitor
New York Considers Transuranic Waste Storage at SPRU

By ExchangeMonitor
Pentagon IG to Evaluate Space, Nuclear and Missile Defense Programs in FY 19

By ExchangeMonitor
NNSA Readies New Funding Deals for Medical Isotope Production

By ExchangeMonitor
Contractor, DOE Intervene in New Mexico Appeal Over WIPP Waste Volume

By ExchangeMonitor
Publication Notice

By ExchangeMonitor